Sign in
Not yet recruitingNo phase

"Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools"

Key facts

Who runs it
Humanitas Clinical and Research Center
Where
Italy2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
45 people, planned
Started
1 Aug 2025
Planned end
1 Aug 2025
Type of study
Observational
Treatments tested
  • mini_FC
Record updated
29 June 2025

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Acute circulatory failure defined as:
  • SAP ≤ 90 mmHg (or a decrease > 50 mm Hg in hypertensive patients)
  • or a mean arterial pressure (MAP) ≤ 70 mmHg
  • or the use of vasopressors to maintain SAP >90 mmHg,
  • associated with skin mottling; tachycardia ≥100 beats/min; urinary flow ≤0.5 mL/kg for at least 2 hours; blood lactate level ≥4 mmol/L

Who cannot take part

  • known severe myocardial or valvular dysfunction
  • cardiac arrhythmias
  • severe acute respiratory distress syndrome
  • on-going haemodialysis or continuous hemofiltration
  • moribund patients
  • persistent low quality of the arterial signal affecting hemodynamic monitoring measurements
  • poor echographic windows

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The mini fluid challenge (mini_FC) is a functional hemodynamic test which has been used in different clinical contexts to assess fluid responsiveness.

Read full original descriptionShow less

This test is performed by rapidly injecting a small aliquot of fluid (100 ml over 1 minute), which is followed by the infusion of the residual aliquot of fluid.

Since the threshold of the mini_FC identified by the literature is rather small (5% of stroke volume (SV) increase after the 100 ml bolus to discriminate between responder and non-responder), it is crucial that the hemodynamic tool assessing this change could be reliable. Moreover, the SV changes with inspiratory/expiratory movements and the increase after the mini_FC should also consider the physiological fluctuations of the SV.

In the literature this test has been performed by means of tolls with different least significant change of the SV. The least significant change (LSC) represents the smallest difference between successive measurements of SV that can be considered to be a real change and not attributable to chance.

The purpose of this study is to assess the agreement among MOSTCARE system (4.5\& of SV LSC described in the literature) and the echocardiography (about 10% of SV LSC described in the literature) with the PICCO system (about 1% of SV LSC described in the literature - considered the gold standard) in discriminating fluid responsiveness after a mini_FC

The group in the trial

  • Intervention _mini_FC

    The fluid challenge consists of 4 ml\*Kg of Crystalloids' solution infused over 10 minutes, administered via either a central or a peripheral line. 1. The patient is already connected to the PICCO monitoring for clinical purpose of hemodynamic monitoring (before study enrollment) 2. The MOSTCARE system is connected to the MONITOR of the patient (and not to the patient itself) by means of a cable inserted into the connections system. 3. The echocardiography will be performed by a senior intensivist/cardiologist. The stroke volume is calculated by measuring VTI and diameter at the same point. This is best performed by measuring the diameter of the LVOT in the parasternal long axis (PLAX) view

    Treatment: mini_FC

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 June 2025